Pharmacotherapy of Bipolar Disorder and Schizophrenia with Co-Occurring Substance Use Disorders Addiction Psychopharmacology of Substance Use Disorders with Concurrent Medical Illness Pharmacotherapy of Depressive and Anxiety Disorders with Co-Occurring Substance Use Disorders Pharmacotherapy of ADHD with Co-Occurring Substance Use Disorders Pharmacotherapy of Post Traumatic Stress Disorder with Co-Occurring Substance Use Disorders Telehealth Treatment of Substance Use Disorders Pharmacotherapy of Substance Use Disorders in Pregnancy Pharmacotherapy of Substance Use Disorders in Adolescents

Saturday, October 5, 2024 12:00 PM-12:05 PM Welcome and Introduction to the Live Session John Mariani, MD and Kevin Sevarino, MD, PhD 12:05 PM-12:45 PM Pharmacotherapy of Substance Use Disorders in Adolescents Justine Welsh, MD 12:45 PM-1:00 PM Break 1:00 PM-1:40 PM Pharmacotherapy: Perinatal Substance Use Disorder Constance Guille, MD 1:40 PM-1:55 PM Break 1:55 PM-2:35 PM Pharmacotherapy of Depressive and Anxiety Disorders with Co-Occurring Substance Use Disorders Edward Nunes, MD 2:35 PM-2:50 PM Break 2:50 PM-3:30 PM Pharmacotherapy of ADHD with Co-Occurring Substance Use Disorders Frances Levin, MD 3:30-3:35 PM End of the Day Wrap Up Sunday, October 6, 2024 12:00 PM-12:05 PM Welcome and Introduction to the Live Session John Mariani, MD and Kevin Sevarino, MD, PhD 12:05 PM-12:45 PM Telehealth Treatment of Substance Use Disorders Christina Brezing, MD 12:45 PM-1:00 PM Break 1:00 PM-1:40 PM Pharmacotherapy of Post Traumatic Stress Disorder with Co-Occurring Substance Use Disorders Ismene Petrakis, MD 1:40 PM-1:55 PM Break 1:55 PM-2:35 PM Pharmacotherapy of Bipolar Disorder and Schizophrenia with Co-Occurring Substance Use Disorders John Mariani, MD 2:35 PM-2:50 PM Break 2:50 PM-3:30 PM Addiction Psychopharmacology in those with Co-Morbid Medical Conditions Kevin Sevarino, MD, PhD 3:30-3:35 PM End of the Day Wrap Up

Accreditation and Designation Statements

Accreditation Statement In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Target Audience Statement This intensive, 15-hour, online course is designed for physicians and other health care professionals who have a foundation in prescribing medication for patients with substance use disorders, including those with co-occurring psychiatric conditions, but would like a deeper understanding of these pharmacotherapies.Credit for this activity is designated for learners in the following ways: Physician Designation Statement American Academy of Addiction Psychiatry designates this Other activity (one portion of this course is an independent online activity and another portion of this course is a live face-to-face educational exchange with a clinical expert responding to learner questions) for a maximum of 15.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Health Professionals Designation Statement Participants will receive a Certificate of Attendance stating this program is designated for 15.25 AMA PRA Category 1 Credits ™. This credit is accepted by the AANP and the AAPA. Credits subject to change

2025 Advanced Addiction Psychopharmacology Course

More information coming soon!

2024 On-Demand Course is available!

This course covers advanced topics in addiction psychopharmacology for clinicians who already have a strong foundation of knowledge. For 2024, a revamped version of this course had our expert faculty focus on pharmacological treatment of co-occurring psychiatric conditions with substance use disorders, which compliments the curriculum offered in 2023 focusing on the pharmacologic treatment of substance use disorders. All lecture recordings and PDF presentation slides of this intensive training are available for purchase as an on-demand course. The 2024 course costs $350 for AAAP members and ABPN Diplomates and $400 for non-members and offers 15.25 CE. Trainees who are AAAP Members (Join for FREE) can purchase this course for $100 (email [email protected] for discount code).

View On-Demand Course

Topics

Pharmacotherapy of Bipolar Disorder and Schizophrenia with Co-Occurring Substance Use Disorders
Addiction Psychopharmacology of Substance Use Disorders with Concurrent Medical Illness
Pharmacotherapy of Depressive and Anxiety Disorders with Co-Occurring Substance Use Disorders
Pharmacotherapy of ADHD with Co-Occurring Substance Use Disorders
Pharmacotherapy of Post Traumatic Stress Disorder with Co-Occurring Substance Use Disorders
Telehealth Treatment of Substance Use Disorders
Pharmacotherapy of Substance Use Disorders in Pregnancy
Pharmacotherapy of Substance Use Disorders in Adolescents

Target Audience

This intensive, 14-hour, online course is designed for physicians and other health care professionals who have a foundation in prescribing medication for patients with substance use disorders, including those with co-occurring psychiatric conditions, but would like a deeper understanding of these pharmacotherapies.

Educational Objectives

Learners who attend this activity will receive a more in-depth educational experience in the pharmacotherapy of substance use disorders and co-occurring conditions and after participating in this course, learners should be able to:

Discuss the pharmacotherapy of bipolar disorder and schizophrenia in patients with co-occurring substance use disorders .
List evidence-based options for anti-depressant and anti-anxiety pharmacotherapy when treating patients with a co-occurring substance use disorders .
Discuss evidence-based pharmacotherapy for treatment of ADHD with co-occurring substance use disorders.
Understand how pharmacotherapy of substance use disorders is modified in the face of medical co-morbidities.
Discuss evidence-based pharmacotherapy for treatment of PTSD with co-occurring substance use disorders.
Discuss evidence-based prescribing practices for substance use disorders via telehealth.
Discuss evidence-based pharmacotherapy for treatment of substance use disorders in pregnancy.
Discuss evidence-based pharmacotherapy for treatment of substance use disorders in adolescents.

Note: You can find previously recorded courses on the Educational Opportunities page.

2025 Advanced Addiction Psychopharmacology Course

Training Events

2024 On-Demand Course is available!

Get involved.
Join AAAP today.

Learn more about The American Journal on Addictions

2025 Advanced Addiction Psychopharmacology Course

Training Events

2024 On-Demand Course is available!

Get involved. Join AAAP today.

Learn more about The American Journal on Addictions

Get involved.
Join AAAP today.